Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Margin

    Back to All Ratios
AARTI PHARMALABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 20.2921.9620.8417.5817.11

What is the latest Core EBITDA Margin ratio of AARTI PHARMALABS ?

The latest Core EBITDA Margin ratio of AARTI PHARMALABS is 20.29 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar202620.29
Mar202521.96
Mar202420.84
Mar202317.58
Mar202217.11

How is Core EBITDA Margin of AARTI PHARMALABS Trending?

Years Core EBITDA Margin % Change
Mar2026 20.29
-7.60
Mar2025 21.96
5.37
Mar2024 20.84
18.54
Mar2023 17.58
2.75
Mar2022 17.11 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Margin ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹8,636.9 Cr 1.9% 12.8% 13.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,679.0 Cr -1.8% -7% 14.3% Stock Analytics
DIVIS LABORATORIES ₹246,408.0 Cr -3.4% 0.4% 58.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,634.0 Cr -2.7% -3.6% 36% Stock Analytics
CIPLA ₹109,063.0 Cr -3.9% -4.7% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,166.0 Cr 3% 6.1% -3.8% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

1.9%

12.8%

13.4%

SENSEX

-3.1%

-6.2%

-11.7%


You may also like the below Video Courses